News and commentary from the world of neurology and neuroscience
Gepant reduced number of monthly migraine days
Findings may influence treatment approaches for some patients
Health news and commentary from around the Web gathered by MedPage Today staff
In pivotal trial, zavegepant demonstrated pain relief as early as 15 minutes